Advertisement

Pituitary

, Volume 22, Issue 6, pp 601–606 | Cite as

The acromegalic spine: fractures, deformities and spinopelvic balance

  • Bruno de Azevedo Oliveira
  • Bruna Araujo
  • Tainá Mafalda dos Santos
  • Bárbara Roberta Ongaratti
  • Carolina Garcia Soares Leães Rech
  • Nelson Pires Ferreira
  • Júlia Fernanda Semmelmann Pereira-Lima
  • Miriam da Costa OliveiraEmail author
Article
  • 51 Downloads

Abstract

Introduction

Axial skeleton arthropathy and osteoporotic vertebral fractures are common findings in acromegalic patients and can result in severe spinal deformity.

Objective

To investigate the presence of spinal fractures and deformities, sagittal imbalances, and spinopelvic compensatory mechanisms in acromegalics.

Patients and methods

58 patients with acromegaly from a referral neuroendocrinology center were prospectively evaluated by panoramic spine radiographs to detect the presence of fractures and scoliosis, to measure thoracic kyphosis, lumbar lordosis (LL), pelvic incidence (PI), pelvic tilt (PT) and sagittal vertical axis (SVA). Sagittal imbalance criteria were considered: thoracic kyphosis > 50°, PI-LL > 10°, PT > 20° and SVA > 5 cm. Their medical records were analyzed for clinical and laboratorial data.

Results

The prevalence of fractures was 13.8%, predominantly in the thoracic spine, with mild and anterior wedge compressions. Scoliosis was present in 34.5% of the cases, all with degenerative lumbar curve apex. Thoracic kyphosis > 50º occurred in 36.8% of patients, PI-LL > 10° in 48.3%, PT > 20° in 41.4% and SVA > 5 cm in 12.1%.

Conclusion

Increased number of vertebral fractures and high prevalence of spinal deformities related to sagittal imbalance were detected, indicating the importance of monitoring bone comorbidities in acromegaly, with radiological evaluation of the spine as part of the follow up.

Keywords

Acromegaly Spinal column Osteoporotic fractures Sagittal balance kyphosis 

Notes

Funding

No funding has been received for this project.

Compliance with ethical standards

Conflict of interest

The authors have no conflicts of interest for this project.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The project was approved by the institution's Research Ethics Committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Español de Acromegalia, REA). Eur J Endocrinol 151:439–446CrossRefGoogle Scholar
  2. 2.
    Dineen R, Stewart PM, Sherlock M (2017) Acromegaly. QJM 110(7):411–420.  https://doi.org/10.1093/qjmed/hcw004 CrossRefPubMedGoogle Scholar
  3. 3.
    Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4–9.  https://doi.org/10.1007/s11102-016-0754-x CrossRefPubMedGoogle Scholar
  4. 4.
    Bollerslev J, Heck A, Olarescu NC (2019) Management of endocrine disease: individualized management of acromegaly. Eur J Endocrinol 1:19–0124.  https://doi.org/10.1530/EJE-19-0124 CrossRefGoogle Scholar
  5. 5.
    Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552–561.  https://doi.org/10.1038/s41574-018-0058-5 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mazziotti G, Frara S, Giustina A (2018) Pituitary diseases and bone. Endocr Rev 39(4):440–488.  https://doi.org/10.1210/er.2018-00005 CrossRefPubMedGoogle Scholar
  7. 7.
    Cobb JR (1948) The American Academy of Orthopedic Surgeons Instructional Course Lectures, vol 5. Edwards, Ann Arbor, MIGoogle Scholar
  8. 8.
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1348.  https://doi.org/10.1002/jbmr.5650080915 CrossRefPubMedGoogle Scholar
  9. 9.
    Schwab F, Ungar B, Blondel B, Buchowski J, Coe J, Deinlein D, DeWald C, Mehdian H, Shaffrey C, Tribus C, Lafage V (2012) Scoliosis research society—Schwab adult spinal deformity classification: a validation study. Spine 37(12):1077–1082.  https://doi.org/10.1097/BRS.0b013e31823e15e2 CrossRefPubMedGoogle Scholar
  10. 10.
    Yang C, Yang M, Chen Y, Wei X, Ni H, Chen Z, Li J, Bai Y, Zhu X, Li M (2015) Radiographic parameters in adult degenerative scoliosis and different parameters between sagittal balanced and imbalanced ADS patients. Medicine 94(29):e1198.  https://doi.org/10.1097/MD.0000000000001198 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Losa M, Von Werder K (1997) Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol 47(2):123–135.  https://doi.org/10.1046/j.1365-2265.1997.2311048.x CrossRefGoogle Scholar
  12. 12.
    Banerjee A, Patel K, Wren AM (2003) Acromegaly—clinical manifestations and diagnosis. Pharm J 13:273–278Google Scholar
  13. 13.
    Melmed S (2006) Medical progress: acromegaly. N Engl J Med. 355(24):2558–2573.  https://doi.org/10.1056/NEJMra062453 CrossRefPubMedGoogle Scholar
  14. 14.
    Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Extensive clinical experience: changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93:2035–2041.  https://doi.org/10.1210/jc.2007-2149 CrossRefPubMedGoogle Scholar
  15. 15.
    Trouillas J (2014) In search of prognostic classification of endocrine pituitary tumors. Endocr Pathol 25:124–132.  https://doi.org/10.1007/s12022-014-9322-y CrossRefPubMedGoogle Scholar
  16. 16.
    Lugo G, Pena L, Cordido F (2012) Clinical manifestations and diagnosis of acromegaly. Int J Endocrinol 2012:540398.  https://doi.org/10.1155/2012/540398 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros ALE, Sosa E, Jervis P, Roldan P, Mendoza V, López-Félix B, Guinto G, (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438–4446.  https://doi.org/10.1210/jc.2014-2670 CrossRefPubMedGoogle Scholar
  18. 18.
    Dreval AV, Trigolosova IV, Misnikova IV, Kovalyova YA, Tishenina RS, Barsukov IA, Vinogradova AV, Wolffenbuttel BH (2014) Prevalence of diabetes mellitus in patients with acromegaly. Endocr Connect 3(2):93–98.  https://doi.org/10.1530/EC-14-0021 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Collao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R (2019) Acromegaly. Nat Rev Dis Primers 5(1):20.  https://doi.org/10.1038/s41572-019-0071-6 CrossRefGoogle Scholar
  20. 20.
    Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):933–3951.  https://doi.org/10.1210/jc.2014-2700 CrossRefGoogle Scholar
  21. 21.
    Abu Dabrh AM, Mohammed K, Asi N, Farah WH, Wang Z, Farah MH, Prokop LJ, Katznelson L, Murad MH (2014) Surgical interventions and medical treatments in treatment-naïve patients with acromegaly. J Clin Endocrinol Metab 99(11):4003–4014.  https://doi.org/10.1210/jc.2014-2900 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kasuki L, Marques NV, Nuez MJ, Leal VL, Chinen RN, Gadelha MR (2013) Acromegalic patients lost to follow-up: a pilot study. Pituitary 16(2):245–250.  https://doi.org/10.1007/s11102-012-0412-x CrossRefPubMedGoogle Scholar
  23. 23.
    Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, François P, Bertherat J, Cortet-Rudelli C, Chanson P (2017) French Acromegaly Registry Group. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176(5), 645–655 Doi: 10.1530/EJE-16-1064.CrossRefGoogle Scholar
  24. 24.
    Dalle Carbonare L, Micheletti V, Cosaro E, Valenti MT, Mottes M, Francia G, Davì MV (2018) Bone histomorphometry in acromegaly patients with fragility vertebral fractures. Pituitary 21:56–64.  https://doi.org/10.1007/s11102-017-0847-1 CrossRefPubMedGoogle Scholar
  25. 25.
    Bonadonna S, Mazziotti G, Nuzzo M, Bianchi A, Fusco A, De Marinis L, Giustina A (2005) Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. J Bone Miner Res 20(10):1837–1844.  https://doi.org/10.1359/JBMR.050603 CrossRefPubMedGoogle Scholar
  26. 26.
    Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93(12):4649–4655.  https://doi.org/10.1210/jc.2008-0791 CrossRefPubMedGoogle Scholar
  27. 27.
    Wassenaar MJ, Biermasz NR, Hamdy NA (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475–483.  https://doi.org/10.1530/EJE-10-1005 CrossRefPubMedGoogle Scholar
  28. 28.
    Padova G, Borzì G, Incorvaia L, Siciliano G, Migliorino V, Vetri M, Tita P (2011) Prevalence of osteoporosis and vertebral fractures in acromegalic patients. Clin Cases Miner Bone Metab 8(3):37–43PubMedPubMedCentralGoogle Scholar
  29. 29.
    Madeira M, Neto LV, de Paula Paranhos Neto F, Barbosa Lima IC, Carvalho de Mendonça LM, Gadelha MR, Fleiuss de Farias ML, (2013) Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 98(4):1734–1741.  https://doi.org/10.1210/jc.2012-4073 CrossRefPubMedGoogle Scholar
  30. 30.
    Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98(8):3402–3410.  https://doi.org/10.1210/jc.2013-1460 CrossRefPubMedGoogle Scholar
  31. 31.
    Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen MJ, Kloppenburg M, Hamdy NA, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98(12):4808–4815.  https://doi.org/10.1210/jc.2013-2695 CrossRefPubMedGoogle Scholar
  32. 32.
    de Herder WW (2016) The history of acromegaly. Neuroendocrinology 103(1):7–17.  https://doi.org/10.1159/000371808 CrossRefPubMedGoogle Scholar
  33. 33.
    AlDallal S (2018) Acromegaly: a challenging condition to diagnose. Int J Gen Med 11:337–343.CrossRefGoogle Scholar
  34. 34.
    Chiloiro S, Mazziotti G, Giampietro A, Bianchi A, Frara S, Mormando M, Pontecorvi A, Giustina A, De Marinis L (2018) Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. Pituitary 21(3):302–308.  https://doi.org/10.1007/s11102-018-0873-7 CrossRefPubMedGoogle Scholar
  35. 35.
    Mammis A, Eloy JA, Liu JK (2010) Early descriptions of acromegaly and gigantism and their historical evolution as clinical entities. Neurosurg Focus 29(4):E1CrossRefGoogle Scholar
  36. 36.
    Scarpa R, De Blasi D, Pivonello R, Marzullo P, Manguso F, Sodano A, Oriente P, Lombardi G, Colao A (2004) Acromegalic axial arthropathy: a clinical case–control study. J Clin Endocrinol Metab 89(2):598–603CrossRefGoogle Scholar
  37. 37.
    Silva FE, Lenke LG (2010) Adult degenerative scoliosis: evaluation and management. Neurosurg Focus 28(3):E1.  https://doi.org/10.3171/2010.7.FOCUS10160 CrossRefPubMedGoogle Scholar
  38. 38.
    Pratali R, Luz CO, Barsotti CEG, Santos FPE, Oliveira CEAS (2014) Analysis of sagittal balance and spinopelvic parameters in a brazilian population sample. Coluna/Columna 13(2):108–111.  https://doi.org/10.1590/S1808-18512014130200399 CrossRefGoogle Scholar
  39. 39.
    Lopes AJ, da Silva DP, Kasuki L, Gadelha MR, Camilo GB, Guimarães FS (2014) Posture and balance control in patients with acromegaly: results of a cross-sectional study. Gait Posture 40(1):154–159.  https://doi.org/10.1016/j.gaitpost.2014.03.014 CrossRefPubMedGoogle Scholar
  40. 40.
    Black DM, Arden NK, Palermo L, Pearson J, Cummings SR (1999) Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 14(5), 821–828 Doi: 10.1359/jbmr.1999.14.5.821.CrossRefGoogle Scholar
  41. 41.
    Melton LJ, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214–221CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Bruno de Azevedo Oliveira
    • 1
  • Bruna Araujo
    • 2
  • Tainá Mafalda dos Santos
    • 2
  • Bárbara Roberta Ongaratti
    • 1
  • Carolina Garcia Soares Leães Rech
    • 2
  • Nelson Pires Ferreira
    • 2
  • Júlia Fernanda Semmelmann Pereira-Lima
    • 1
    • 2
  • Miriam da Costa Oliveira
    • 1
    • 2
    Email author
  1. 1.Programa de Pós-Graduação Em PatologiaUniversidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)Porto AlegreBrasil
  2. 2.Centro de Neuroendocrinologia, Complexo Hospitalar Santa Casa, UFCSPAPorto AlegreBrasil

Personalised recommendations